RxDoctor Payments Data

Jason Durel, MD

Otolaryngology · Lafayette, LANPI 1669664934

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,125 of the $4,351 with a category attached, or 71.8%. It is spread thinly across 24 manufacturers, the largest accounting for just 20.4%.

$4,351in general payments, 2019–2025

Across 144 payments — averaging $30.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$887
  • Optinose US, Inc.$556
  • Sanofi$443
  • Smith+Nephew$442
  • Stryker$345
  • Regeneron Healthcare Solutions, Inc.$324
  • plus $1K from 18 others

What the payments were for

  • Speaking & faculty fees$75017%
  • Travel & lodging$44210%
  • Food & beverage$3,12572%
  • Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,351 in reported general payments places this provider in the 80th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana

Medicare billing

Part B allowed, 2024
$250,929
Medicare patients
533
Services billed
3,437

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate564$7,625
Azelastine Hcl232$5,923
Ipratropium Bromide97$2,958
Cefdinir84$1,700
Ofloxacin48$1,472
Omeprazole78$829
Famotidine97$816
Montelukast Sodium62$537
Levocetirizine Dihydrochloride21$524
Pantoprazole Sodium69$425
Amoxicillin54$286
Methylprednisolone52$253
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen39$178
Mupirocin25$163
Doxycycline Hyclate11$97

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →